Luis Geovanny Escobar Ronquillo

Luis Geovanny Escobar Ronquillo

Auto-generated profile, based on publicly available information

Luis Geovanny Escobar Ronquillo

Universidad de Especialidades Espíritu Santo

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in ACTA DE OTORRINOLARINGOLOGÍA & CIRUGÍA DE CABEZA Y CUELLO
Verified
Journal Article
Open access
PDF file
PAPaulina Elizabeth Bombón Albán
Paulina Elizabeth Bombón Albán
LRLuís Geovanny Escobar Ronquillo
Luís Geovanny Escobar Ronquillo
CCChristian Adrián Cisneros-Hinostroza
Christian Adrián Cisneros-Hinostroza
Introduction: Coronavirus disease 2019 is a pandemic disease that has caused more than six million deaths worldwide. The clinical picture of the infection can vary depending on the severity of the disease and usually includes general, ENT and neurological symptoms. Objective: To provide a narrative review of the scientific literature on the clinical diagnosis and treatment of olfactory dysfunction related to coronavirus disease 2019. Results: Olfactory dysfunction defined as the reduced or distorted ability to smell when inhaling (orthonasal smell) or when eating (postnasal smell), is often reported in mild or even asymptomatic cases. The prevalenceof olfactory dysfunction can vary with respect to the clinical setting, with rates of total loss of smell as high as 70% in patients with mild coronavirus disease 2019. In addition, to date there is a paucity of articles prospectively evaluating recovery rates of olfactory dysfunction in patients with coronavirus disease 2019. Conclusion: Coronavirus disease 2019 is associated with olfactory dysfunction in variouspatients. Active and collaborative research is required to delineate the natural history and appropriate management of olfactory dysfunction in this virulent disease. In the meantime, diagnosis and targeted treatments such as olfactory training may be helpfulin olfactory dysfunction related to coronavirus disease 2019.

22 January 2025 in Arandu UTIC
Verified
Journal Article
Open access
PDF file
LRLuis Geovanny Escobar Ronquillo
Luis Geovanny Escobar Ronquillo
NJNatalia Moreano Jalil
Natalia Moreano Jalil
PLPablo Leon
Pablo Leon
MPMarcela del Rocio Arellano Ponce
Marcela del Rocio Arellano Ponce
CSCristhian Stalin Sánchez Sellán
Cristhian Stalin Sánchez Sellán
Los errores en la administración de medicamentos constituyen una de las principales causas de eventos adversos en los hospitales y representan un riesgo significativo para la seguridad del paciente. Estos errores pueden producirse en diversas etapas del proceso, como la prescripción, la preparación y la administración, y se deben a factores como sobrecarga laboral, comunicación ineficaz y ausencia de protocolos hospitalarios unificados. Este artículo revisa las causas más comunes de estos errores y propone estrategias para fomentar una cultura de seguridad y prevención. Entre las principales medidas, destacan la aplicación de los “Cinco Correctos” (paciente correcto, medicamento correcto, dosis correcta, vía y momento correctos), el uso de tecnología de prescripción electrónica y la incorporación de sistemas de verificación por códigos de barras. Asimismo, se hace hincapié en la formación continua del personal de salud y en la importancia de reportar los incidentes sin penalizaciones, con el fin de identificar áreas de oportunidad y fortalecer la mejora continua. En última instancia, abordar de manera integral la problemática de los errores en la administración de medicamentos requiere la colaboración de todos los profesionales involucrados, promoviendo un entorno de confianza y aprendizaje que garantice la atención de mayor calidad para los pacientes.

8 October 2025 in International Science Journal
Verified
Journal Article
Closed access
ARArizbeth Miroslava Pinales Ramírez
Arizbeth Miroslava Pinales Ramírez
PJPamela Elizabeth Peñaloza Jiménez
Pamela Elizabeth Peñaloza Jiménez
KCKarla Stefanny Naranjo Calvachi
Karla Stefanny Naranjo Calvachi
JLJesús Ricardo Jiménez López
Jesús Ricardo Jiménez López
JHJohn Anthony García Hernández
John Anthony García Hernández
EREloisa Vanessa Suárez Ruiz
Eloisa Vanessa Suárez Ruiz
Regenerative medicine has rapidly evolved into a central pillar of aesthetic and reconstructive surgery, integrating cellular therapies, autologous biologics, biomaterials and advanced biofabrication platforms. This review synthesizes evidence from twenty peer-reviewed studies to examine how these modalities contribute to tissue restoration, improve structural and functional outcomes and reshape surgical practice. Cell-based approaches—particularly mesenchymal and adipose-derived stem cells—emerged as the most frequently investigated strategies, reflecting their capacity to modulate inflammation, enhance angiogenesis and promote extracellular matrix remodeling. Autologous biologics such as platelet-rich plasma and regenerative fat grafting also demonstrated widespread application due to their accessibility and compatibility with established clinical workflows. Concurrently, biomaterial-based techniques and 3D bioprinting technologies are expanding reconstructive possibilities, enabling more personalized and anatomically precise interventions. Across indications ranging from facial rejuvenation and breast reconstruction to cartilage engineering and wound repair, regenerative modalities consistently demonstrated potential to improve tissue quality and aesthetic outcomes. Although heterogeneity in protocols and limited long-term data remain challenges, the convergence of biological science, materials engineering and surgical innovation positions regenerative medicine as a transformative paradigm for future clinical practice.

8 October 2025 in International Science Journal
Verified
Journal Article
Closed access
IVIrlanda Lince Flores del Valle
Irlanda Lince Flores del Valle
ARArizbeth Miroslava Pinales Ramírez
Arizbeth Miroslava Pinales Ramírez
LRLuis Geovanny Escobar Ronquillo
Luis Geovanny Escobar Ronquillo
KCKarla Stefanny Naranjo Calvachi
Karla Stefanny Naranjo Calvachi
ÁAÁngela Patricia López Alvarado
Ángela Patricia López Alvarado
RGRicardo Daniel Corona González
Ricardo Daniel Corona González
Population health in the 21st century is shaped by the convergence of chronic disease burdens, emergent infectious threats, environmental pressures and widening social inequities. This review analyzes epidemiologic dynamics in Mexico, Colombia and Ecuador within the broader global context, integrating findings from mortality patterns, behavioral and metabolic risk profiles, structural determinants and health-system capacities. Results indicate that the three countries share an advanced epidemiologic transition dominated by noncommunicable diseases, while still experiencing persistent communicable threats and injury-related mortality. Elevated levels of obesity, hypertension and physical inactivity contribute to an intensified risk environment compared with global averages, reflecting rapid lifestyle and urban transitions. Social determinants—including inequality, urbanization and variable access to primary care—further differentiate population vulnerabilities. Additionally, substantial variation in preventive capacity and epidemiologic intelligence underscores systemic disparities in preparedness and response. The findings highlight the need for integrated, multilevel preventive strategies that address metabolic risks, strengthen primary care, reduce inequities and modernize surveillance systems. This study contributes to a nuanced understanding of how diverse structural and epidemiologic forces shape population health trajectories in the 21st century.

27 December 2025 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
JAJorge Ozziel Badillo Avalos
Jorge Ozziel Badillo Avalos
CBCesar Emmanuel Abarca Becerril
Cesar Emmanuel Abarca Becerril
ARAdrián Jesús Santoyo Rojas
Adrián Jesús Santoyo Rojas
SMSantiago Xavier Bucheli Machado
Santiago Xavier Bucheli Machado
MCMadelayne Cecilia Enriquez Cobos
Madelayne Cecilia Enriquez Cobos
LNLuis Gabriel Beltran Narvaez
Luis Gabriel Beltran Narvaez
Upper airway disorders are traditionally approached as localized conditions affecting the nasal cavity, paranasal sinuses, pharynx, and related structures. However, accumulating evidence indicates that these disorders exert clinically meaningful systemic effects through interconnected physiological, inflammatory, and neurohumoral mechanisms. This narrative integrative review examines the systemic clinical implications of major upper airway disorders, including obstructive sleep apnea, allergic rhinitis, chronic rhinosinusitis, and tonsillopharyngitis. The analysis integrates epidemiological data, mechanistic insights, and clinical outcome evidence to characterize how upper airway dysfunction contributes to cardiovascular disease, metabolic dysregulation, neurocognitive impairment, immune and inflammatory alterations, and lower-airway comorbidity. The findings highlight distinct systemic association profiles across conditions: obstructive sleep apnea demonstrates strong links with cardiovascular, metabolic, and neurocognitive domains, whereas allergic rhinitis and chronic rhinosinusitis are more closely associated with immune-mediated pathways and lower-airway disease within the unified airway framework. Tonsillopharyngitis shows a more focused inflammatory profile with limited multisystem extension. Collectively, the evidence supports a systems-based perspective in which upper airway disorders are understood as modifiers of systemic health rather than isolated local diseases. This integrative approach has important implications for medical education, interdisciplinary clinical practice, and early identification of systemic risk, particularly in healthcare contexts with high burdens of chronic disease.

9 February 2026 in ACTA DE OTORRINOLARINGOLOGÍA & CIRUGÍA DE CABEZA Y CUELLO
Verified
Journal Article
Open access
PDF file
LRLuis Geovanny Escobar Ronquillo
Luis Geovanny Escobar Ronquillo
CSClaudia Nicole Aguilar Sánchez
Claudia Nicole Aguilar Sánchez
MPMildred Carolin Aguilar Piguave
Mildred Carolin Aguilar Piguave
Introducción: La rinosinusitis crónica con poliposis nasal (RSCcPN) se asocia a inflamación eosinofílica tipo 2, provocando obstrucción nasal y disfunción olfativa. Este trabajo analiza la evidencia sobre medicamentos biológicos en RSCcPN, enfatizando las implicaciones y barreras de América Latina. Materiales y métodos: revisión narrativa mediante búsqueda bibliográfica exhaustiva en bases como EBSCO. Discusión: fármacos como dupilumab, omalizumab y mepolizumab (anti-Il-4Ra, IgE e IL-5) están aprobados en EE. UU., mientras el benralizumab (anti-IL-5Ra) continúa en evaluación. Conclusiones: las terapias biológicas son eficaces y seguras para pacientes refractarios. Sin embargo, en Latinoamérica la implementación es limitada por falta de acceso y protocolos, lo que evidencia la urgente necesidad de desarrollar guías clínicas regionales.